Mylan to sell up to $363 million stake in India's Biocon, term sheet shows

Mylan ​Inc plans to ‌sell ⁠up ⁠to 92 ​million shares in ​Indian drugmaker ​Biocon ⁠Ltd, worth ‌up ​to ​34.81 ⁠billion Indian rupees ($363 ​million), according to ​a term ‌sheet seen ​by ​Reuters.

Raccontata dam.economictimes.com